Interferon-free antiviral therapy does not increase the risk of developing short term hepatocellular carcinoma in patients with cirrhosis infected with hepatitis C virus

被引：1
|
作者：
Nunez, A. [1 ]
Aguilera, V. [1 ]
Sanchez-Torrijos, Y. [1 ]
Sousa, J. M. [1 ,2 ]
Ferrer, M. T. [1 ,2 ]
Giraldez, A. [1 ,2 ]
Ampuero, J. [3 ,4 ]
Perez-Martinez, J. [1 ]
Cuaresma, M. [2 ,5 ]
Ruiz-Perez, R. [2 ,5 ]
Pascasio, J. M. [3 ,4 ]
机构：
[1] Hosp Univ Virgen del Rocio, Digest Dis, Seville, Spain
[2] Hosp Univ Virgen del Rocio, IBIS, Seville, Spain
[3] Hosp Univ Virgen del Rocio, IBIS, Digest Dis, Seville, Spain
[4] Hosp Univ Virgen del Rocio, CIBERehd, Seville, Spain
[5] Hosp Univ Virgen del Rocio, FISEVI, Seville, Spain
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(17)31325-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-131
引用
收藏
页码：S469 / S469
页数：1
相关论文
共 50 条
  • [41] Hepatic decompensation associated with an interferon-free antiviral therapy in patients with HCV-cirrhosis
    Batskikh, S. N.
    Vinnitskaya, E. V.
    Sandler, Yu G.
    Khaimenova, T. Yu
    TERAPEVTICHESKII ARKHIV, 2018, 90 (11) : 67 - 73
  • [42] Safety and Efficacy of Interferon-free Antiviral Therapy in Patients with Recurrent Hepatitis C after Liver Transplantation
    Zanaga, L.
    Giorgetti, A.
    Coris Arrelaro, R.
    Ataide, E.
    Boin, I.
    Silveira Bello Stucchi, R.
    TRANSPLANTATION, 2017, 101 (05) : 290 - 290
  • [43] Interferon-free direct-acting antiviral therapy for acute hepatitis C virus infection in HIV-infected individuals: A literature review
    Lampejo, Temi
    Agarwal, Kosh
    Carey, Ivana
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : 113 - 123
  • [44] Persistent mixed cryoglobulinaemia vasculitis despite hepatitis C virus eradication after interferon-free antiviral therapy
    Sollima, Salvatore
    Milazzo, Laura
    Peri, Anna Maria
    Torre, Alessandro
    Antinori, Spinello
    Galli, Massimo
    RHEUMATOLOGY, 2016, 55 (11) : 2084 - 2085
  • [45] Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients
    Merchante, Nicolas
    Rodriguez-Arrondo, Francisco
    Revollo, Boris
    Merino, Esperanza
    Ibarra, Sofia
    Galindo, Maria J.
    Montero, Marta
    Garcia-Deltoro, Miguel
    Rivero-Juarez, Antonio
    Tellez, Francisco
    Delgado-Fernandez, Marcial
    Rios-Villegas, Maria J.
    Garcia, Maria A.
    Vera-Mendez, Francisco J.
    Ojeda-Burgos, Guillermo
    Lopez-Ruz, Miguel A.
    Metola, Luis
    Omar, Mohamed
    Remedios Aleman-Valls, Maria
    Aguirrebengoa, Koldo
    Portu, Joseba
    Raffo, Miguel
    Macias, Juan
    Pineda, Juan A.
    AIDS, 2018, 32 (11) : 1423 - 1430
  • [46] Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy
    Urbanowicz, Arkadiusz
    Zagozdzon, Radoslaw
    Ciszek, Michal
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2019, 67 (02) : 79 - 88
  • [47] Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy
    Arkadiusz Urbanowicz
    Radosław Zagożdżon
    Michał Ciszek
    Archivum Immunologiae et Therapiae Experimentalis, 2019, 67 : 79 - 88
  • [48] Prevalence and risk factors of hepatitis B virus reactivation in interferon-free direct-acting antiviral therapies for hepatitis C
    Kawagishi, N.
    Suda, G.
    Onozawa, M.
    Kimura, M.
    Maehara, O.
    Ohara, M.
    Izumi, T.
    Umemura, M.
    Ito, J.
    Nakai, M.
    Sho, T.
    Natsuizka, M.
    Morikawa, K.
    Ogawa, K.
    Sakamoto, N.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S725 - S726
  • [49] Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia Vasculitis
    Cacoub, Patrice
    Ahmed, Si Nafa Si
    Ferfar, Yasmina
    Pol, Stanislas
    Thabut, Dominique
    Hezode, Christophe
    Alric, Laurent
    Comarmond, Cloe
    Ragab, Gafaar
    Quartuccio, Luca
    Hegazy, Mohamed
    Poynard, Thierry
    Rigon, Matthieu Resche
    Saadoun, David
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (03) : 518 - 526
  • [50] Interferon Reduces the Risk of Hepatocellular Carcinoma in Hepatitis C Virus-Related Chronic Hepatitis/Liver Cirrhosis
    Masuzaki, Ryota
    Yoshida, Haruhiko
    Omata, Masao
    ONCOLOGY, 2010, 78 : 17 - 23
12345